Search Results - "Haroche, J."

Drug‐induced sarcoidosis: an overview of the WHO pharmacovigilance database by Cohen Aubart, F., Lhote, R., Amoura, A., Valeyre, D., Haroche, J., Amoura, Z., Lebrun‐Vignes, B.

“…Background There is a documented association between drug exposure and sarcoidosis‐like reactions. In this study, we used the largest pharmacovigilance…”
Get full text

Cutaneous manifestations of paediatric Erdheim–Chester disease, a histiocytosis of the ‘L’ group by Chasset, F., Haroche, J.

“…Linked Article: Su et al. Br J Dermatol 2018; 178:261–264…”
Get full text

The cerebrospinal fluid CD4/CD8 ratio and interleukin‐6 and ‐10 levels in neurosarcoidosis: a multicenter, pragmatic, comparative study by Chazal, T., Costopoulos, M., Maillart, E., Fleury, C., Psimaras, D., Legendre, P., Pineton de Chambrun, M., Haroche, J., Lubetzki, C., Amoura, Z., Legarff‐Tavernier, M., Cohen Aubart, F.

“…Background and purpose Neurosarcoidosis is a rare inflammatory disorder of unknown cause. The aim of this study was to evaluate the value of T/B lymphocyte…”
Get full text

Endocrine Manifestations in a Monocentric Cohort of 64 Patients With Erdheim-Chester Disease by Courtillot, C, Laugier Robiolle, S, Cohen Aubart, F, Leban, M, Renard-Penna, R, Drier, A, Charlotte, F, Amoura, Z, Touraine, P, Haroche, J

“…Context: Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis, characterized by infiltration of foamy histiocytes in multiple organs…”
Get full text

Management of giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA) by Bienvenu, B., Ly, K.H., Lambert, M., Agard, C., André, M., Benhamou, Y., Bonnotte, B., de Boysson, H., Espitia, O., Fau, G., Fauchais, A.-L., Galateau-Sallé, F., Haroche, J., Héron, E., Lapébie, F.-X., Liozon, E., Luong Nguyen, L.B., Magnant, J., Manrique, A., Matt, M., de Menthon, M., Mouthon, L., Puéchal, X., Pugnet, G., Quemeneur, T., Régent, A., Saadoun, D., Samson, M., Sène, D., Smets, P., Yelnik, C., Sailler, L., Mahr, A.

“…Management of giant cell arteritis (GCA, Horton's disease) involves many uncertainties. This work was undertaken to establish French recommendations for GCA…”
Get full text

Pulmonary fibrosis associated with ANCA-positive vasculitides. Retrospective study of 12 cases and review of the literature by Hervier, B, Pagnoux, C, Agard, C, Haroche, J, Amoura, Z, Guillevin, L, Hamidou, M A

“…To describe the clinical presentation of the association between pulmonary fibrosis (PF) and systemic vasculitis related to antineutrophil cytoplasmic…”
Get more information

MRI features of intra-axial histiocytic brain mass lesions by Luna, L.P., Drier, A., Aygun, N., Mokhtari, K., Hoang-Xuan, K., Galanaud, D., Donadieu, J., Dormont, D., Haroche, J., Martin-Duverneuil, N.

“…To describe MRI features, including diffusion-weighted imaging (DWI), magnetic resonance spectroscopy (MRS), and perfusion-weighted imaging (PWI), of…”
Get full text

Sarcoidosis occurring during BRAF/MEK inhibitors is associated with paradoxical ERK activation in Erdheim‐Chester patients by Amoura, A., Haroche, J., Emile, J.‐F., Barete, S., Helias‐Rodzewicz, Z., Charlotte, F., Maisonobe, T., Amoura, Z., Cohen Aubart, F.

Get full text

Systemic lupus erythematosus associated with ANCA-associated vasculitis: an overlapping syndrome? by Hervier, B., Hamidou, M., Haroche, J., Durant, C., Mathian, A., Amoura, Z.

“…Systemic lupus erythematosus (SLE) and small-sized vessel vasculitis are usually two distinguishable autoimmune diseases. However, a vasculitis may be found in…”
Get full text

The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature by Jallouli, M., Saadoun, D., Eymard, B., Leroux, G., Haroche, J., Le Thi Huong, D., De Gennes, C., Chapelon, C., Benveniste, O., Wechsler, B., Cacoub, P., Amoura, Z., Piette, J. C., Costedoat-Chalumeau, N.

“…The coexistence of systemic lupus erythematosus (SLE) and myasthenia gravis (MG) is rarely reported, and most of the published studies are case reports…”
Get full text

Rosai-Dorfman disease: Diagnosis and therapeutic challenges by Cohen Aubart, F, Haroche, J, Emile, J-F, Charlotte, F, Barete, S, Schleinitz, N, Donadieu, J, Amoura, Z

“…Rosai-Dorfman disease (RDD) was first described by the French pathologist Paul Destombes in 1965. It frequently affects children or young adults and is…”
Get full text

Letter to the editor regarding the article entitled «COVID-19 and medical publications: How three articles have influenced the media and public decisions in France by Amoura, Z, Miyara, M, Tubach, F, Pourcher, V, Morélot-Panzini, C, Haroche, J, Gorochov, G, Caumes, E, Hausfater, P, Combes, A, Similowski, T

Get full text

Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature by Leroux, G., Sellam, J., Costedoat-Chalumeau, N., Le Thi Huong, D., Combes, A., Tieulié, N., Haroche, J., Amoura, Z., Nieszkowska, A., Chastre, J., Dormont, D., Piette, J-C.

“…Posterior reversible encephalopathy syndrome (PRES) associates various neurological manifestations (headaches, seizures, altered mental status, cortical…”
Get full text

Use of targeting therapy in Erdheim-Chester disease: A case report with neurologic involvement by Berthe, P, Rouzic, N, Daelman, L, Jacobzone, C, Espitia, A, Cohen-Aubart, F, Haroche, J, Émile, J-F, Lorleac'h, A

“…Erdheim-Chester disease (ECD) is a rare multisystemic disease characterised by an infiltration of various organs by CD68 CD1a histiocytes. The clinical and…”
Get full text

Factors influencing the efficacy of two injections of a pandemic 2009 influenza A (H1N1) nonadjuvanted vaccine in systemic lupus erythematosus by Mathian, A., Devilliers, H., Krivine, A., Costedoat‐Chalumeau, N., Haroche, J., Huong, D. Boutin‐Le Thi, Wechsler, B., Hervier, B., Miyara, M., Morel, N., Le Corre, N., Arnaud, L., Piette, J. C., Musset, L., Autran, B., Rozenberg, F., Amoura, Z.

“…Objective To assess the factors influencing the efficacy of 2 injections of a pandemic 2009 influenza A (H1N1) vaccine in patients with systemic lupus…”
Get full text

Langerhans cell histiocytosis and Erdheim-Chester disease, a continuity? by Parreau, S, Haroche, J, Pommepuy, I, Emile, J F, Bourras, J C, Archambeaud, F

“…Erdheim-Chester disease and langerhans cell histiocytosis are two rare diseases separate on clinical, radiological and histological aspects. However, several…”
Get full text

Long term activity of vemurafenib in cancers with BRAF mutations: the ACSE basket study for advanced cancers other than BRAFV600-mutated melanoma by Blay, J.Y., Cropet, C., Mansard, S., Loriot, Y., De La Fouchardière, C., Haroche, J., Topart, D., Tougeron, D., You, B., Italiano, A., Le Brun-Ly, V., Ferrero, J.M., Penel, N., Fabbro, M., Troussard, X., Malka, D., Ray-Coquard, I., Leboulleux, S., Fléchon, A., Maubec, E., Charles, J., Dalle, S., Taieb, S., Garcia, G.C.T.E., Mandache, A.M., Colignon, N., Gavrel, M., Nowak, F., Hoog Labouret, N., Mahier Aït Oukhatar, C., Gomez-Roca, C.

“…BRAF inhibitors are approved in BRAFV600-mutated metastatic melanoma, non-small-cell lung cancer (NSCLC), Erdheim–Chester disease (ECD), and thyroid cancer. We…”
Get full text

Neurosarcoidosis: Diagnosis and therapeutic issues by Cohen Aubart, F, Galanaud, D, Haroche, J, Psimaras, D, Mathian, A, Hié, M, Le-Thi Huong Boutin, D, Charlotte, F, Maillart, E, Maisonobe, T, Amoura, Z

“…Neurological localizations of sarcoidosis are heterogeneous and may affect virtually every part of the central or peripheral nervous system. They are often the…”
Get full text

Sarcoidosis flare after autologous stem cell transplantation: An immune paradox? by Marchal, A, Charlotte, F, Maksud, P, Haroche, J, Lifferman, F, Miyara, M, Choquet, S, Amoura, Z, Cohen Aubart, F

“…Sarcoidosis is a systemic granulomatous disorder of unknown cause. Apparition or flare of previously diagnosed sarcoidosis following hematopoietic stem cell…”
Get full text

Cardiac sarcoidosis: Diagnosis and therapeutic challenges by Cohen Aubart, F, Nunes, H, Mathian, A, Haroche, J, Hié, M, Le-Thi Huong Boutin, D, Cluzel, P, Soussan, M, Waintraub, X, Fouret, P, Valeyre, D, Amoura, Z

“…Sarcoidosis is a granulomatous disorder of unknown cause characterized by non-caseating granuloma in young adults. Cardiac involvement is rare and range from 2…”
Get full text